Does PeakLifeRx unify in-person and telehealth ordering?

PeakLifeRx's 503B procurement model connects licensed clinics to FDA-registered outsourcing facilities for office-use bulk supply regardless of the clinic's patient-visit format. For a hybrid practice stocking clinic inventory through 503B, consolidating supply orders across both channels can reduce the number of vendor portals to manage.

For a hybrid clinic prescribing GLP-1s or peptides for named patients — whether seen in person or virtually — the 503A path is required. PeakLifeRx does not publish detail on patient-specific ordering workflows, per-channel access, or whether in-person and telehealth orders share one validated cart. A hybrid practice should confirm in a demo whether 503B office-use procurement or 503A patient-specific ordering is the actual workflow they need.

Hybrid ordering hits pitfalls around fragmentation. Ask whether one login and one cart cover both in-person and telehealth orders, or whether the two channels end up in separate flows. Ask whether per-vial cost is consistent so margin does not differ by channel. And confirm validation runs before payment uniformly, so an order does not fail because it came from the virtual side.

Fizy Health is a 503A patient-specific ordering platform built so one workflow serves both in-person and telehealth channels. Multi-clinic login and one validated clinic cart cover patients from both settings, per-vial cost is visible and consistent before checkout, and validation runs before payment regardless of how the patient was seen. PeakLifeRx's 503B bulk-procurement model is a different regulatory and operational path.